Praluent (alirocumab)

**Product type:** Human Prescription Drug

**Active ingredient:** ALIROCUMAB

**Strength:** 150 mg/mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Sanofi-Aventis U.S. LLC

**Marketing category:** BLA (BLA125559)

**Pharmacologic class:** Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA]